THE DEFINITIVE GUIDE TO PHARMACEUTICAL INGREDIENTS

“The current scenario has uncovered some structural weaknesses inside the EU’s medicines offer chain as well as a superior dependence on non-EU nations around the world for active pharmaceutical ingredients,” Kyriakides explained. She recommended that offer chain difficulties be addressed in an EU pharmaceutical tactic predicted being release